MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/13872877251322196

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2025

Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.

Zhang Chunhua, Tai Yaojun, Kong Min, Jia Pengyuan, Ma Guozhao, Ba Maowen, for Alzheimer's Disease Neuroimaging Initiative

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BackgroundThe pathological hallmarks of Alzheimer's disease (AD) include the amyloid-β (Aβ) plaques and phosphorylated tau (p-tau) forming neurofibrillary tangles. Understanding the pathophysiological cascade related to Aβ and tau process is crucial.ObjectiveTo investigate the impact of Aβ positron emission tomography (PET) and cerebrospinal fluid (CSF) p-tau on tau pathology and cognitive decline in AD.MethodsWe analyzed 319 older individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI) who underwent Aβ (18F-florbetapir or 18F-florbetaben) and tau (18F-flortaucipir) PET scans, along with CSF and cognitive assessments. Aβ positivity (A+) was determined by global standardized uptake value ratio thresholds of ≥1.11 for 18F-florbetapir or ≥1.08 for 18F-florbetaben, while p-tau positivity (T+) was defined as CSF p-tau181 levels ≥23 pg/ml. Linear mixed regression models were used to assess the effects of PET Aβ and CSF p-tau181 levels on tau accumulation in predefined Braak regions and cognitive function over time.ResultsOur results revealed significant differences in PET tau pathology and cognitive decline between A + and A- individuals. We observed that interactions between Aβ and p-tau proteins were associated with tau accumulation and cognitive decline. Additionally, A-/T + individuals exhibited higher levels of tau accumulation in all Braak regions compared to A-/T- counterparts, suggesting a potential independent role of p-tau in tau pathology in the absence of Aβ.ConclusionsOur findings suggest that Aβ positivity and elevated CSF p-tau181 levels were associated with tau accumulation and cognitive decline, highlighting the relevance of soluble p-tau as a potential biomarker for further investigation.

Для цитирования: Zhang Chunhua, Tai Yaojun, Kong Min, Jia Pengyuan, Ma Guozhao, Ba Maowen, for Alzheimer's Disease Neuroimaging Initiative. Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.. Journal of Alzheimer's disease : JAD. 2025. DOI: 10.1177/13872877251322196.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.